Stem Cell and Biologic Scaffold Engineering
Tissue engineering and regenerative medicine is a rapidly evolving research field which effectively combines stem cells and biologic scaffolds in order to replace damaged tissues. Biologic scaffolds can be produced through the removal of resident cellular populations using several tissue engineering...
Saved in:
: | |
---|---|
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 electronic resource (110 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993548397004498 |
---|---|
ctrlnum |
(CKB)4100000010106172 (oapen)https://directory.doabooks.org/handle/20.500.12854/60016 (EXLCZ)994100000010106172 |
collection |
bib_alma |
record_format |
marc |
spelling |
Mallis, Panagiotis auth Stem Cell and Biologic Scaffold Engineering MDPI - Multidisciplinary Digital Publishing Institute 2019 1 electronic resource (110 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Tissue engineering and regenerative medicine is a rapidly evolving research field which effectively combines stem cells and biologic scaffolds in order to replace damaged tissues. Biologic scaffolds can be produced through the removal of resident cellular populations using several tissue engineering approaches, such as the decellularization method. Indeed, the decellularization method aims to develop a cell-free biologic scaffold while keeping the extracellular matrix (ECM) intact. Furthermore, biologic scaffolds have been investigated for their in vitro potential for whole organ development. Currently, clinical products composed of decellularized matrices, such as pericardium, urinary bladder, small intestine, heart valves, nerve conduits, trachea, and vessels, are being evaluated for use in human clinical trials. Tissue engineering strategies require the interaction of biologic scaffolds with cellular populations. Among them, stem cells are characterized by unlimited cell division, self-renewal, and differentiation potential, distinguishing themselves as a frontline source for the repopulation of decellularized matrices and scaffolds. Under this scheme, stem cells can be isolated from patients, expanded under good manufacturing practices (GMPs), used for the repopulation of biologic scaffolds and, finally, returned to the patient. The interaction between scaffolds and stem cells is thought to be crucial for their infiltration, adhesion, and differentiation into specific cell types. In addition, biomedical devices such as bioreactors contribute to the uniform repopulation of scaffolds. Until now, remarkable efforts have been made by the scientific society in order to establish the proper repopulation conditions of decellularized matrices and scaffolds. However, parameters such as stem cell number, in vitro cultivation conditions, and specific growth media composition need further evaluation. The ultimate goal is the development of “artificial” tissues similar to native ones, which is achieved by properly combining stem cells and biologic scaffolds and thus bringing them one step closer to personalized medicine. The original research articles and comprehensive reviews in this Special Issue deal with the use of stem cells and biologic scaffolds that utilize state-of-the-art tissue engineering and regenerative medicine approaches. English nerve conduit tissue engineering regenerative medicine mixed lymphocyte reaction histological images future scaffold engineering multiparameter 3DPVS MSCs Wnt signaling Mesenchymal Stromal Cells factorial design novel scaffold Wharton’s Jelly tissue stem cells umbilical arteries SDS platelet rich plasma TGF? signaling traditional scaffold pluripotency and commitment tissue engineered construct HLA-G CHAPS platelets proteomic analysis vibrating nature of universe. VS55 cell culture FGF signaling evolution of scaffold dynamicity and dimensionality fibrin gel scaffold classification decellularization vitrification seven-folder logics IIEF-5 questionnaire TGF-?1 erectile dysfunction human induced pluripotent stem cells iPSCs scaffolds Barret’s esophagus nerve regeneration long term storage laws of system evolution scaffold categorization platelet lysate 3D scaffold esophagus language of relativity cord blood units 3-03921-497-7 |
language |
English |
format |
eBook |
author |
Mallis, Panagiotis |
spellingShingle |
Mallis, Panagiotis Stem Cell and Biologic Scaffold Engineering |
author_facet |
Mallis, Panagiotis |
author_variant |
p m pm |
author_sort |
Mallis, Panagiotis |
title |
Stem Cell and Biologic Scaffold Engineering |
title_full |
Stem Cell and Biologic Scaffold Engineering |
title_fullStr |
Stem Cell and Biologic Scaffold Engineering |
title_full_unstemmed |
Stem Cell and Biologic Scaffold Engineering |
title_auth |
Stem Cell and Biologic Scaffold Engineering |
title_new |
Stem Cell and Biologic Scaffold Engineering |
title_sort |
stem cell and biologic scaffold engineering |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2019 |
physical |
1 electronic resource (110 p.) |
isbn |
3-03921-498-5 3-03921-497-7 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT mallispanagiotis stemcellandbiologicscaffoldengineering |
status_str |
n |
ids_txt_mv |
(CKB)4100000010106172 (oapen)https://directory.doabooks.org/handle/20.500.12854/60016 (EXLCZ)994100000010106172 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Stem Cell and Biologic Scaffold Engineering |
_version_ |
1787551963031797761 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04975nam-a2200901z--4500</leader><controlfield tag="001">993548397004498</controlfield><controlfield tag="005">20231214133537.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03921-498-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010106172</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/60016</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010106172</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mallis, Panagiotis</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Stem Cell and Biologic Scaffold Engineering</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (110 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tissue engineering and regenerative medicine is a rapidly evolving research field which effectively combines stem cells and biologic scaffolds in order to replace damaged tissues. Biologic scaffolds can be produced through the removal of resident cellular populations using several tissue engineering approaches, such as the decellularization method. Indeed, the decellularization method aims to develop a cell-free biologic scaffold while keeping the extracellular matrix (ECM) intact. Furthermore, biologic scaffolds have been investigated for their in vitro potential for whole organ development. Currently, clinical products composed of decellularized matrices, such as pericardium, urinary bladder, small intestine, heart valves, nerve conduits, trachea, and vessels, are being evaluated for use in human clinical trials. Tissue engineering strategies require the interaction of biologic scaffolds with cellular populations. Among them, stem cells are characterized by unlimited cell division, self-renewal, and differentiation potential, distinguishing themselves as a frontline source for the repopulation of decellularized matrices and scaffolds. Under this scheme, stem cells can be isolated from patients, expanded under good manufacturing practices (GMPs), used for the repopulation of biologic scaffolds and, finally, returned to the patient. The interaction between scaffolds and stem cells is thought to be crucial for their infiltration, adhesion, and differentiation into specific cell types. In addition, biomedical devices such as bioreactors contribute to the uniform repopulation of scaffolds. Until now, remarkable efforts have been made by the scientific society in order to establish the proper repopulation conditions of decellularized matrices and scaffolds. However, parameters such as stem cell number, in vitro cultivation conditions, and specific growth media composition need further evaluation. The ultimate goal is the development of “artificial” tissues similar to native ones, which is achieved by properly combining stem cells and biologic scaffolds and thus bringing them one step closer to personalized medicine. The original research articles and comprehensive reviews in this Special Issue deal with the use of stem cells and biologic scaffolds that utilize state-of-the-art tissue engineering and regenerative medicine approaches.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nerve conduit</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tissue engineering</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">regenerative medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mixed lymphocyte reaction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">histological images</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">future scaffold engineering</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiparameter</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">3DPVS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MSCs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Wnt signaling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mesenchymal Stromal Cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">factorial design</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">novel scaffold</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Wharton’s Jelly tissue</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stem cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">umbilical arteries</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SDS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">platelet rich plasma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TGF? signaling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">traditional scaffold</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pluripotency and commitment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tissue engineered construct</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HLA-G</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CHAPS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">platelets</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteomic analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vibrating nature of universe.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VS55</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell culture</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FGF signaling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">evolution of scaffold</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dynamicity and dimensionality</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fibrin gel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">scaffold classification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">decellularization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vitrification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">seven-folder logics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IIEF-5 questionnaire</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TGF-?1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">erectile dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human induced pluripotent stem cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iPSCs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">scaffolds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Barret’s esophagus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nerve regeneration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long term storage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">laws of system evolution</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">scaffold categorization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">platelet lysate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">3D scaffold</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">esophagus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">language of relativity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cord blood units</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03921-497-7</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:57:17 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-02-01 22:26:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338781660004498&Force_direct=true</subfield><subfield code="Z">5338781660004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338781660004498</subfield></datafield></record></collection> |